{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T05:18:15Z","timestamp":1767676695805,"version":"3.40.5"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["Z01-HD008920-01"],"award-info":[{"award-number":["Z01-HD008920-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular and Cellular Endocrinology"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.mce.2016.08.004","type":"journal-article","created":{"date-parts":[[2016,8,5]],"date-time":"2016-08-05T15:39:21Z","timestamp":1470411561000},"page":"165-174","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Celecoxib treatment of fibrous dysplasia (FD) in a human FD cell line and FD-like lesions in mice with protein kinase A (PKA) defects"],"prefix":"10.1016","volume":"439","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0485-0120","authenticated-orcid":false,"given":"Emmanouil","family":"Saloustros","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sisi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward L.","family":"Mertz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nisan","family":"Bhattacharyya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew F.","family":"Starost","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paraskevi","family":"Salpea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Nesterova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Collins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergey","family":"Leikin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Constantine A.","family":"Stratakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mce.2016.08.004_bib1","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.prostaglandins.2006.09.005","article-title":"Effects of selective prostaglandins E2 receptor agonists on cultured calvarial murine osteoblastic cells","volume":"81","author":"Alander","year":"2006","journal-title":"Prostagl. Other Lipid Mediat"},{"key":"10.1016\/j.mce.2016.08.004_bib2","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/hmg\/ddq455","article-title":"Protein kinase A regulates caspase-1 via Ets-1 in bone stromal cell-derived lesions: a link between cyclic AMP and pro-inflammatory pathways in osteoblast progenitors","volume":"20","author":"Almeida","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.mce.2016.08.004_bib3","doi-asserted-by":"crossref","first-page":"E687","DOI":"10.1210\/jc.2011-3000","article-title":"Activation of cyclic AMP signaling leads to different pathway alterations in lesions of the adrenal cortex caused by germline PRKAR1A defects versus those due to GNAS mutations","volume":"97","author":"Almeida","year":"2012","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2016.08.004_bib4","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1749-6632.2002.tb04328.x","article-title":"The essential role of RI alpha in the maintenance of regulated PKA activity","volume":"968","author":"Amieux","year":"2002","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.mce.2016.08.004_bib5","doi-asserted-by":"crossref","first-page":"27294","DOI":"10.1074\/jbc.M200302200","article-title":"Increased basal cAMP-dependent protein kinase activity inhibits the formation of mesoderm-derived structures in the developing mouse embryo","volume":"277","author":"Amieux","year":"2002","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.mce.2016.08.004_bib6","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1056\/NEJMoa061652","article-title":"Celecoxib for the prevention of colorectal adenomatous polyps","volume":"355","author":"Arber","year":"2006","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.mce.2016.08.004_bib7","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1056\/NEJMoa061355","article-title":"Celecoxib for the prevention of sporadic colorectal adenomas","volume":"355","author":"Bertagnolli","year":"2006","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.mce.2016.08.004_bib8","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1002\/jbmr.1546","article-title":"Mechanism of FGF23 processing in fibrous dysplasia","volume":"27","author":"Bhattacharyya","year":"2012","journal-title":"J.\u00a0Bone Min. Res."},{"key":"10.1016\/j.mce.2016.08.004_bib9","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1172\/JCI2361","article-title":"Reproduction of human fibrous dysplasia of bone in immunocompromised mice by transplanted mosaics of normal and Gsalpha-mutated skeletal progenitor cells","volume":"101","author":"Bianco","year":"1998","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.mce.2016.08.004_bib10","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.tem.2009.12.004","article-title":"Prostaglandins in bone: bad cop, good cop?","volume":"21","author":"Blackwell","year":"2010","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.mce.2016.08.004_bib11","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1002\/jbmr.1603","article-title":"Denosumab treatment for fibrous dysplasia","volume":"27","author":"Boyce","year":"2012","journal-title":"J.\u00a0Bone Min. Res."},{"key":"10.1016\/j.mce.2016.08.004_bib12","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/00005792-198507000-00007","article-title":"The complex of myxomas, spotty pigmentation, and endocrine overactivity","volume":"64","author":"Carney","year":"1985","journal-title":"Med. Baltim."},{"key":"10.1016\/j.mce.2016.08.004_bib13","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/00000478-200102000-00004","article-title":"Osteochondromyxoma of bone: a congenital tumor associated with lentigines and other unusual disorders","volume":"25","author":"Carney","year":"2001","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.mce.2016.08.004_bib14","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ydbio.2005.10.013","article-title":"Fishing for prostanoids: deciphering the developmental functions of cyclooxygenase-derived prostaglandins","volume":"289","author":"Cha","year":"2006","journal-title":"Dev. Biol."},{"key":"10.1016\/j.mce.2016.08.004_bib15","doi-asserted-by":"crossref","first-page":"3673","DOI":"10.1038\/ncomms4673","article-title":"G-protein stimulatory subunit alpha and Gq\/11alpha G-proteins are both required to maintain quiescent stem-like chondrocytes","volume":"5","author":"Chagin","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mce.2016.08.004_bib16","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1016\/j.ajpath.2014.05.023","article-title":"Mammalian target of rapamycin complex 1 and cyclooxygenase 2 pathways cooperatively exacerbate endometrial cancer","volume":"184","author":"Daikoku","year":"2014","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.mce.2016.08.004_bib17","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1517\/14740338.2013.780595","article-title":"Safety of celecoxib compared with placebo and non-selective NSAIDs: cumulative meta-analysis of 89 randomized controlled trials","volume":"12","author":"Essex","year":"2013","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.mce.2016.08.004_bib18","series-title":"Bone Histomorphometry. Techniques and Interpretations. Boca Raton (FL)","first-page":"109","article-title":"Bone histomorphometry: analysis of trabecular bone dynamics","author":"Frost","year":"1983"},{"key":"10.1016\/j.mce.2016.08.004_bib19","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/carcin\/bgp014","article-title":"The COX-2\/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment","volume":"30","author":"Greenhough","year":"2009","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.mce.2016.08.004_bib20","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/79238","article-title":"Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex","volume":"26","author":"Kirschner","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.mce.2016.08.004_bib21","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1093\/hmg\/9.20.3037","article-title":"Genetic heterogeneity and spectrum of mutations of the PRKAR1A gene in patients with the carney complex","volume":"9","author":"Kirschner","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.mce.2016.08.004_bib22","doi-asserted-by":"crossref","first-page":"4506","DOI":"10.1158\/0008-5472.CAN-05-0580","article-title":"A\u00a0mouse model for the Carney complex tumor syndrome develops neoplasia in cyclic AMP-responsive tissues","volume":"65","author":"Kirschner","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.mce.2016.08.004_bib23","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1365-2796.2009.02114.x","article-title":"Use of mouse models to understand the molecular basis of tissue-specific tumorigenesis in the Carney complex","volume":"266","author":"Kirschner","year":"2009","journal-title":"J.\u00a0Intern Med."},{"key":"10.1016\/j.mce.2016.08.004_bib24","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1093\/annonc\/mdm544","article-title":"Irinotecan combined with infusional 5-fluorouracil\/folinic acid or capecitabine plus celecoxib or placebo in the first-line treatment of patients with metastatic colorectal cancer. EORTC study 40015","volume":"19","author":"Kohne","year":"2007","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.mce.2016.08.004_bib25","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1210\/endo-86-6-1436","article-title":"Prostaglandins: stimulation of bone resorption in tissue culture","volume":"86","author":"Klein","year":"1970","journal-title":"Endocrinology"},{"key":"10.1016\/j.mce.2016.08.004_bib26","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/nature14034","article-title":"Blocking PGE2-induced tumour repopulation abrogates bladder cancer chemoresistance","volume":"517","author":"Kurtova","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.mce.2016.08.004_bib27","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.arth.2013.06.039","article-title":"Celecoxib and heterotopic bone formation after total hip arthroplasty","volume":"29","author":"Lavernia","year":"2014","journal-title":"J.\u00a0Arthroplasty"},{"key":"10.1016\/j.mce.2016.08.004_bib28","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/sj.bjc.6602942","article-title":"COX inhibitors and breast cancer","volume":"94","author":"Mazhar","year":"2006","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.mce.2016.08.004_bib29","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.1172\/JCI42391","article-title":"Prkar1a is an osteosarcoma tumor suppressor that defines a molecular subclass in mice","volume":"120","author":"Molyneux","year":"2010","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.mce.2016.08.004_bib30","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/nature05883","article-title":"Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasis","volume":"447","author":"North","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.mce.2016.08.004_bib31","doi-asserted-by":"crossref","first-page":"256","DOI":"10.5301\/hipint.5000109","article-title":"Effect of a selective COX-2 inhibitor, celecoxib, on heterotopic ossification after total hip arthroplasty: a case-controlled study","volume":"24","author":"Oni","year":"2014","journal-title":"Hip Int."},{"key":"10.1016\/j.mce.2016.08.004_bib32","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1210\/me.2007-0369","article-title":"Mutation of Prkar1a causes osteoblast neoplasia driven by dysregulation of protein kinase A","volume":"22","author":"Pavel","year":"2008","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.mce.2016.08.004_bib33","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1007\/s00198-006-0142-x","article-title":"The effect of cyclooxygenase-2 inhibitors on bone mineral density: results from the Canadian Multicentre Osteoporosis Study","volume":"17","author":"Richards","year":"2006","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.mce.2016.08.004_bib34","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1002\/jcb.24485","article-title":"Cancer cell killing by Celecoxib: reality or just in\u00a0vitro precipitation-related artifact?","volume":"114","author":"Sacchetti","year":"2013","journal-title":"J.\u00a0Cell Biochem."},{"key":"10.1016\/j.mce.2016.08.004_bib35","doi-asserted-by":"crossref","first-page":"e1000980","DOI":"10.1371\/journal.pgen.1000980","article-title":"Cushing's syndrome and fetal features resurgence in adrenal cortex-specific Prkar1a knockout mice","volume":"6","author":"Sahut-Barnola","year":"2010","journal-title":"PLoS Genet."},{"key":"10.1016\/j.mce.2016.08.004_bib36","doi-asserted-by":"crossref","first-page":"16206","DOI":"10.1074\/jbc.M109.078576","article-title":"Embryonic expression of cyclooxygenase-2 causes malformations in axial skeleton","volume":"285","author":"Shim","year":"2010","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.mce.2016.08.004_bib37","doi-asserted-by":"crossref","first-page":"500","DOI":"10.2106\/JBJS.F.00127","article-title":"Dose and time-dependent effects of cyclooxygenase-2 inhibition on fracture-healing","volume":"89","author":"Simon","year":"2007","journal-title":"J.\u00a0Bone Jt. Surg. Am."},{"key":"10.1016\/j.mce.2016.08.004_bib38","doi-asserted-by":"crossref","first-page":"4041","DOI":"10.1210\/jcem.86.9.7903","article-title":"Clinical and molecular features of the Carney complex: diagnostic criteria and recommendations for patient evaluation","volume":"86","author":"Stratakis","year":"2001","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2016.08.004_bib39","doi-asserted-by":"crossref","first-page":"8683","DOI":"10.1073\/pnas.1003680107","article-title":"Alternate protein kinase A activity identifies a unique population of stromal cells in adult bone","volume":"107","author":"Tsang","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mce.2016.08.004_bib40","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0092-8674(00)81433-6","article-title":"Cyclooxygenase regulates angiogenesis induced by colon cancer cells","volume":"93","author":"Tsujii","year":"1998","journal-title":"Cell."},{"key":"10.1016\/j.mce.2016.08.004_bib41","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/ng.153","article-title":"Mutations in 15-hydroxyprostaglandin dehydrogenase cause primary hypertrophic osteoarthropathy","volume":"40","author":"Uppal","year":"2008","journal-title":"Nat. Genet."},{"key":"10.1016\/j.mce.2016.08.004_bib42","doi-asserted-by":"crossref","first-page":"3492","DOI":"10.1172\/JCI46406","article-title":"Gsalpha enhances commitment of mesenchymal progenitors to the osteoblast lineage but restrains osteoblast differentiation in mice","volume":"121","author":"Wu","year":"2011","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.mce.2016.08.004_bib43","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1161\/CIRCULATIONAHA.107.759233","article-title":"Heart-specific ablation of Prkar1a causes failure of heart development and myxomagenesis","volume":"117","author":"Yin","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.mce.2016.08.004_bib44","doi-asserted-by":"crossref","first-page":"744","DOI":"10.3892\/mco.2014.319","article-title":"Cyclooxygenase-2 inhibitors for non-small-cell lung cancer: a phase II trial and literature review","volume":"2","author":"Yokouchi","year":"2014","journal-title":"Mol. Clin. Oncol."},{"key":"10.1016\/j.mce.2016.08.004_bib45","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1172\/JCI0215681","article-title":"Cyclooxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair","volume":"109","author":"Zhang","year":"2002","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.mce.2016.08.004_bib46","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1055\/s-0032-1321845","article-title":"Different roles of GNAS and cAMP signaling during early and late stages of osteogenic differentiation","volume":"44","author":"Zhang","year":"2012","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.mce.2016.08.004_bib47","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaa2340","article-title":"Tissue Regeneration. Inhibition of the prostaglandin-degrading enzyme 15-PGDH potentiates tissue regeneration","volume":"348","author":"Zhang","year":"2015","journal-title":"Science"}],"container-title":["Molecular and Cellular Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720716302945?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720716302945?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,12]],"date-time":"2019-09-12T03:25:07Z","timestamp":1568258707000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303720716302945"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":47,"alternative-id":["S0303720716302945"],"URL":"https:\/\/doi.org\/10.1016\/j.mce.2016.08.004","relation":{},"ISSN":["0303-7207"],"issn-type":[{"type":"print","value":"0303-7207"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Celecoxib treatment of fibrous dysplasia (FD) in a human FD cell line and FD-like lesions in mice with protein kinase A (PKA) defects","name":"articletitle","label":"Article Title"},{"value":"Molecular and Cellular Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mce.2016.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ireland Ltd.","name":"copyright","label":"Copyright"}]}}